The current status of clinics providing private practice cell therapy in Japan

Written by Regenerative Medicine

A Preliminary Communication investigating the current state of clinics in Japan that offer unproven cell therapies, by Misao Fujita, Taichi Hatta, Reina Ozeki, Akira Akabayashi (Kyoto University and The University of Tokyo, Japan).

Little is known about the state of clinics in Japan carrying out unproven cell therapies, and it is therefore difficult to know information such as the types of therapies they provide, and to ascertain the effect that the Act on the Safety of Regenerative Medicine
(ASRM), created in Japan in November 2014, may have had in regulating
these clinics.

In this Preliminary Communication, Misao Fujita, Taichi Hatta, Reina Ozeki, Akira Akabayashi from Kyoto University and The University of Tokyo (Japan) demonstrate the results of an online analysis of publicly available information on the websites of clinics providing private practice cell therapies, carried out in May 2014 before the ASRM enactment.

Fujita M, Hatta T, Ozeki R, Akabayashi A. The current status of clinics providing private practice cell therapy in Japan. Regen. Med. 11(1), 23—32 (2016).